Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis

Carla Abrahamian(Deutsches Herzzentrum München), Christian Grimm(Fraunhofer Institute for Translational Medicine and Pharmacology)
Nature Communications
November 19, 2024
Cited by 20


Related Papers